[Managing patients with left ventricular thrombosis after acute myocardial infarction: current evidence,

Francesca Giordana1, Giulia Bugani2, Massimiliano Camilli3

  • 1U.O.C. Cardiologia, Azienda Ospedaliera Santa Croce e Carle, Cuneo.

Giornale Italiano Di Cardiologia (2006)
|February 28, 2023
PubMed

Insights

Left ventricular thrombosis (LVT) incidence has decreased post-myocardial infarction. Embolic events remain a concern despite anticoagulation, with Vitamin K antagonists preferred over newer agents.

Area of Science:

  • Cardiology
  • Thrombosis Research

Context:

  • Left ventricular thrombosis (LVT) incidence has declined due to improved revascularization and antithrombotic therapies post-acute myocardial infarction.
  • Embolic events are the primary complication of LVT, even with oral anticoagulation.
  • LVT pathogenesis involves Virchow's triad: endothelial damage, blood stasis, and hypercoagulability.

Purpose:

  • To review the current understanding of left ventricular thrombosis (LVT) following acute myocardial infarction.
  • To discuss diagnostic modalities and therapeutic strategies for LVT.
  • To evaluate the role of screening and prophylactic anticoagulation.

Summary:

  • Diagnostic tools for LVT include contrast-enhanced echocardiography and cardiac magnetic resonance.
  • Thrombi typically form within two weeks post-myocardial infarction, limiting the utility of serial imaging.
  • Vitamin K antagonists are the current standard of care; direct oral anticoagulant efficacy is unproven. Prophylactic anticoagulation shows limited evidence.

Impact:

  • Highlights the evolving landscape of LVT management after myocardial infarction.
  • Underscores the persistent risk of embolic complications.
  • Informs clinical practice regarding diagnostic screening and therapeutic choices for LVT.

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
15
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
19
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
20
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
13
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
23
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
31